Related Experiment Videos
Inflammatory bowel disease in children
1Section of Gastroenterology and Hepatology, Children's Hospital of Philadelphia, Pennsylvania.
Insights
Inflammatory Bowel Disease (IBD) in children presents unique challenges, impacting growth and psychological well-being. Optimal management requires understanding pediatric-specific differences for better outcomes.
Area of Science:
- Pediatric Gastroenterology
- Chronic Disease Management
- Inflammatory Bowel Disease (IBD)
Background:
- Inflammatory Bowel Disease (IBD), encompassing Ulcerative Colitis (UC) and Crohn's Disease (CD), significantly affects children and adolescents.
- While sharing similarities with adult IBD, pediatric cases present unique challenges in presentation, disease course, and management.
- Endoscopic evaluations of the colon and terminal ileum are feasible in most pediatric patients.
Purpose of the Study:
- To highlight the distinct aspects of pediatric Inflammatory Bowel Disease (IBD) compared to adult IBD.
- To emphasize the critical need for pediatric-specific research and management strategies.
- To underscore the importance of addressing growth, pubertal development, and psychological impact in pediatric IBD.
Main Methods:
- Review of existing literature and clinical understanding of pediatric Inflammatory Bowel Disease (IBD).
- Analysis of challenges in extrapolating adult IBD data to pediatric populations.
- Emphasis on the necessity of tailored therapeutic assessments for growth and development.
Main Results:
- Growth failure due to malnutrition is a serious complication in pediatric IBD patients.
- The psychological impact on children and families is substantial.
- Limited controlled studies specific to pediatric IBD have historically complicated management.
Conclusions:
- Managing pediatric IBD requires a deep understanding of differences from adult IBD to optimize growth and minimize long-term sequelae.
- Collaborative research efforts are crucial for advancing the optimal care of children and adolescents with IBD.
- Future research should focus on therapies that address both disease activity and developmental outcomes.
Abstract:
IBD is one of the most significant chronic diseases afflicting children and adolescents. As in adults, UC and CD constitute the two major disease entities, with many of the characteristics of these two diseases being similar in adults and children. With technical advances, a complete endoscopic examination of the colon and terminal ileum can be performed in most children without difficulty. There are, however, a number of aspects of the presentation, course, and management of these diseases that are unique to the pediatric population. Because the impact of inadequate nutrition is much greater in the growing child than in adults, growth failure is a common, serious complication of malnutrition in this population. The psychological impact of a chronic illness on both the developing child and the family can also be significant. The management of this population is further complicated by the lack of adequate studies that assess not only the effect of a medical or surgical therapy on disease activity, but also address the issues of growth and pubertal development. It has been a challenge to extrapolate data from adult studies to the pediatric population. The management of children and adolescents requires a critical understanding of the differences between pediatric and adult patients to maximize growth potential and minimize longterm sequelae of treatment. After a long period of limited controlled studies, however, collaborative efforts are underway to investigate most aspects of pediatric IBD, and we look forward to exciting advances toward the optimal management of children and adolescents with IBD.